Zevra Therapeutics, Inc.
ZVRA
Cena:
Valuace
70
Růst
63
Zdraví
50
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
ZEVRA THERAPEUTICS PRESENTS POSITIVE NEW REAL-WORLD DATA ON MIPLYFFA® IN PATIENTS WITH NEIMANN-PICK DISEASE TYPE C (NPC) AT THE 22ND ANNUAL WORLDSYMPOSIUM™
04-02-2026
REAL-WORLD AND CLINICAL TRIAL DATA UNDERSCORE LONG-TERM SAFETY AND EFFECTIVENESS IN PEDIATRIC AND AD...
Více zde
ZEVRA THERAPEUTICS TO RING NASDAQ STOCK MARKET OPENING BELL ON MONDAY, FEBRUARY 9, 2026
02-02-2026
CELEBRATION, FLA., FEB. 02, 2026 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA THERAPEUTICS TO PRESENT MULTIPLE ANALYSES ON MIPLYFFA® AT THE 22ND ANNUAL WORLDSYMPOSIUM™
26-01-2026
FOUR ABSTRACTS HIGHLIGHTING CLINICAL DATA AND REAL-WORLD EXPERIENCE WITH MIPLYFFA ACCEPTED FOR PRESE...
Více zde
ZEVRA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
12-12-2025
CELEBRATION, FLA., DEC. 12, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA THERAPEUTICS, INC. APPOINTS ALICIA SECOR TO BOARD OF DIRECTORS; ANNOUNCES RETIREMENT OF WENDY DIXON, PHD
02-12-2025
CELEBRATION, FLA., DEC. 02, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA THERAPEUTICS, INC. ANNOUNCES CFO TRANSITION
20-11-2025
CELEBRATION, FLA., NOV. 20, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND CORPORATE UPDATE
05-11-2025
2025 EPS OF $(0.01) Q3 2025 NET REVENUE OF $26.1 MILLION , DRIVEN BY MIPLYFFA ® NET REVENUE OF $22....
Více zde
ZEVRA THERAPEUTICS TO PARTICIPATE IN THE GUGGENHEIM HEALTHCARE INNOVATION CONFERENCE
29-10-2025
CELEBRATION, FLA., OCT. 29, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA THERAPEUTICS ANNOUNCES DETAILS FOR Q3 2025 FINANCIAL RESULTS CALL
27-10-2025
- COMPANY WILL HOST CONFERENCE CALL AT 4:30 P.M. ET ON WEDNESDAY, NOVEMBER 5, 2025 - COMPANY WILL HO...
Více zde
ZEVRA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
06-10-2025
CELEBRATION, FLA., OCT. 06, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA THERAPEUTICS ANNOUNCES UPCOMING ORAL PRESENTATION AT THE INTERNATIONAL NIEMANN-PICK DISEASE ALLIANCE (INPDA) MEETING AND POSTER PRESENTATIONS AT THE CHILD NEUROLOGY SOCIETY (CNS) CONFERENCE ON MIPLYFFA® (ARIMOCLOMOL) AND OLPRUVA® (SODIUM PHENYLBUTYR
18-09-2025
MIPLYFFA, THE ONLY THERAPY FOR NIEMANN-PICK DISEASE TYPE C (NPC) SHOWN TO STOP DISEASE PROGRESSION A...
Více zde
ZEVRA THERAPEUTICS PRESENTS POSITIVE NEW DATA SUPPORTING FOUNDATIONAL ROLE OF MIPLYFFA® (ARIMOCLOMOL) FOR THE TREATMENT OF NIEMANN-PICK DISEASE TYPE C AT THE INTERNATIONAL CONGRESS OF INBORN ERRORS OF METABOLISM (ICIEM)
04-09-2025
NEW DATA FROM PRE-SPECIFIED ANALYSIS SHOWS PATIENTS ON CONCOMITANT MIGLUSTAT WHO SWITCHED FROM PLACE...
Více zde
ZEVRA THERAPEUTICS ANNOUNCES MULTIPLE DATASETS ON MIPLYFFA® (ARIMOCLOMOL) TO BE PRESENTED AT THE INTERNATIONAL CONGRESS OF INBORN ERRORS OF METABOLISM (ICIEM)
28-08-2025
CELEBRATION, FLA., AUG. 28, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA THERAPEUTICS TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES IN SEPTEMBER
26-08-2025
CELEBRATION, FLA., AUG. 26, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND CORPORATE UPDATE
12-08-2025
Q2 2025 NET REVENUE OF $25.9 MILLION , DRIVEN BY PRODUCT NET REVENUE OF $21.8 MILLION...
Více zde
ZEVRA THERAPEUTICS ANNOUNCES DETAILS FOR Q2 2025 FINANCIAL RESULTS CALL
04-08-2025
COMPANY WILL HOST CONFERENCE CALL AT 4:30 P.M. ET, ON TUESDAY, AUGUST 12, 2025 COMPANY WILL HOST CON...
Více zde
ZEVRA THERAPEUTICS SUBMITS MARKETING AUTHORIZATION APPLICATION TO EUROPEAN MEDICINES AGENCY TO REVIEW ARIMOCLOMOL FOR THE TREATMENT OF NIEMANN-PICK DISEASE TYPE C
28-07-2025
CELEBRATION, FLA., JULY 28, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA THERAPEUTICS ANNOUNCES MIPLYFFA® AND OLPRUVA® PRESENTATIONS AT THE ANNUAL MEETING OF THE SOUTHEASTERN REGIONAL GENETICS GROUP (SERGG)
18-07-2025
CELEBRATION, FLA., JULY 18, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA THERAPEUTICS ANNOUNCES OPEN LABEL EXTENSION DATA SHOWING SUSTAINED LONG-TERM EFFICACY OF MIPLYFFA FOR THE TREATMENT OF NPC PUBLISHED IN THE JOURNAL OF MOLECULAR GENETICS AND METABOLISM
16-07-2025
CELEBRATION, FLA., JULY 16, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA ANNOUNCES FINAL RESULTS OF 2025 ANNUAL MEETING OF STOCKHOLDERS
29-05-2025
ZEVRA STOCKHOLDERS RE-ELECT WENDY L. DIXON, PH.D....
Více zde
ALL THREE LEADING PROXY ADVISORY FIRMS – ISS, GLASS LEWIS, AND EGAN-JONES – RECOMMEND ZEVRA STOCKHOLDERS VOTE FOR THE COMPANY'S DIRECTOR NOMINEES
21-05-2025
ISS, GLASS LEWIS, AND EGAN-JONES UNANIMOUSLY CONCLUDE MANGLESS HAS NOT MADE A COMPELLING CASE FOR CH...
Více zde
ZEVRA THERAPEUTICS ANNOUNCES DETAILS FOR Q1 2025 FINANCIAL RESULTS CALL
06-05-2025
COMPANY WILL HOST CONFERENCE CALL AT 4:30 P.M. ET ON TUESDAY, MAY 13, 2025 COMPANY WILL HOST CONFERE...
Více zde
ZEVRA ANNOUNCES PUBLICATION OF MIPLYFFA® MECHANISM OF ACTION MANUSCRIPT IN MOLECULAR GENETICS AND METABOLISM
17-04-2025
CELEBRATION, FLA., APRIL 17, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEV...
Více zde
ZEVRA ANNOUNCES CLOSING OF SALE OF RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER FOR $150 MILLION
07-04-2025
CELEBRATION, FLA., APRIL 07, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEV...
Více zde
ZEVRA THERAPEUTICS FILES PRELIMINARY PROXY
31-03-2025
CONFIRMS RECEIPT OF TWO DIRECTOR NOMINEES FROM DANIEL J. MANGLESS STOCKHOLDERS ARE NOT REQUIRED TO T...
Více zde
ZEVRA REPORTS FULL YEAR 2024 AND FOURTH QUARTER FINANCIAL RESULTS
11-03-2025
FY 2024 NET REVENUE OF $23.6 MILLION, DRIVEN BY NET REVENUE OF $12.0 MILLION DURING FOURTH QUARTER ...
Více zde
ZEVRA LAUNCHES NEW DISEASE STATE AWARENESS CAMPAIGN, ‘LEARN NPC, READ BETWEEN THE SIGNS,' TO DRIVE EARLY RECOGNITION AND TREATMENT OF NIEMANN-PICK DISEASE TYPE C
28-02-2025
NEW DISEASE STATE AWARENESS CAMPAIGN, ‘LEARN NPC, READ BETWEEN THE SIGNS,' TO DRIVE EARLY RECOGNIT...
Více zde
ZEVRA THERAPEUTICS ENTERS AGREEMENT TO SELL ITS RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER FOR $150 MILLION
27-02-2025
CELEBRATION, FLA., FEB. 27, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
ZEVRA TO REPORT 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
26-02-2025
COMPANY WILL HOST CONFERENCE CALL ON TUESDAY, MAR. 11, 2025, AT 4:30 P.M. ET COMPANY WILL HOST CONFE...
Více zde
ZEVRA TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES
24-02-2025
CELEBRATION, FLA., FEB. 24, 2025 (GLOBE NEWSWIRE) -- ZEVRA THERAPEUTICS, INC. (NASDAQGS: ZVRA) (ZEVR...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2025-12-17 00:00:00 | 8-K |  | Stáhnout |
| 2025-12-02 00:00:00 | 8-K | | Stáhnout |
| 2025-11-20 00:00:00 | 8-K | | Stáhnout |
| 2025-11-05 00:00:00 | 8-K | | Stáhnout |
| 2025-11-05 00:00:00 | 10-Q | | Stáhnout |
| 2025-08-12 01:00:00 | 8-K | | Stáhnout |
| 2025-08-12 01:00:00 | 10-Q | | Stáhnout |
| 2025-08-12 00:00:00 | 8-K | | Stáhnout |
| 2025-08-12 00:00:00 | 10-Q | | Stáhnout |
| 2025-05-29 01:00:00 | 8-K | | Stáhnout |
| 2025-05-29 00:00:00 | 8-K | | Stáhnout |
| 2025-05-13 01:00:00 | 8-K | | Stáhnout |
| 2025-05-13 01:00:00 | 10-Q | | Stáhnout |
| 2025-05-13 00:00:00 | 8-K | | Stáhnout |
| 2025-05-13 00:00:00 | 10-Q | | Stáhnout |
| 2025-04-07 01:00:00 | 8-K | | Stáhnout |
| 2025-04-07 00:00:00 | 8-K | | Stáhnout |
| 2025-03-12 00:00:00 | 10-K | | Stáhnout |
| 2025-03-11 23:00:00 | 10-K | | Stáhnout |
| 2025-03-11 00:00:00 | 8-K | | Stáhnout |
| 2025-03-10 23:00:00 | 8-K | | Stáhnout |
| 2025-02-27 00:00:00 | 8-K | | Stáhnout |
| 2025-02-26 23:00:00 | 8-K | | Stáhnout |
| 2024-12-06 00:00:00 | 8-K | | Stáhnout |
| 2024-12-05 23:00:00 | 8-K | | Stáhnout |
| 2024-11-22 00:00:00 | 8-K | | Stáhnout |
| 2024-11-21 23:00:00 | 8-K | | Stáhnout |
| 2024-11-13 00:00:00 | 10-Q | | Stáhnout |
| 2024-11-12 23:00:00 | 10-Q | | Stáhnout |
| 2024-11-12 00:00:00 | 8-K | | Stáhnout |
| 2024-11-11 23:00:00 | 8-K | | Stáhnout |
| 2024-09-20 01:00:00 | 8-K | | Stáhnout |
| 2024-09-20 00:00:00 | 8-K | | Stáhnout |
| 2024-08-14 01:00:00 | 10-Q | | Stáhnout |
| 2024-08-14 00:00:00 | 10-Q | | Stáhnout |
| 2024-08-13 01:00:00 | 8-K | | Stáhnout |
| 2024-08-13 00:00:00 | 8-K | | Stáhnout |
| 2024-08-09 01:00:00 | 8-K | | Stáhnout |
| 2024-08-09 00:00:00 | 8-K | | Stáhnout |
| 2024-08-08 01:00:00 | 8-K | | Stáhnout |
| 2024-08-08 00:00:00 | 8-K | | Stáhnout |
| 2024-08-05 01:00:00 | 8-K | | Stáhnout |
| 2024-08-05 00:00:00 | 8-K | | Stáhnout |
| 2024-07-12 01:00:00 | 8-K | | Stáhnout |
| 2024-07-12 00:00:00 | 8-K | | Stáhnout |
| 2024-07-09 01:00:00 | 8-K | | Stáhnout |
| 2024-07-09 00:00:00 | 8-K | | Stáhnout |
| 2024-06-03 01:00:00 | 8-K | | Stáhnout |
| 2024-06-03 00:00:00 | 8-K | | Stáhnout |
| 2024-05-13 01:00:00 | 8-K | | Stáhnout |
| 2024-05-13 00:00:00 | 8-K | | Stáhnout |
| 2024-05-09 01:00:00 | 10-Q | | Stáhnout |
| 2024-05-09 00:00:00 | 10-Q | | Stáhnout |
| 2024-05-08 01:00:00 | 8-K | | Stáhnout |
| 2024-05-08 00:00:00 | 8-K | | Stáhnout |
| 2024-04-10 01:00:00 | 8-K | | Stáhnout |
| 2024-04-10 00:00:00 | 8-K | | Stáhnout |
| 2024-04-01 01:00:00 | 10-K | | Stáhnout |
| 2024-04-01 00:00:00 | 10-K | | Stáhnout |
| 2024-03-28 00:00:00 | 8-K | | Stáhnout |
| 2024-03-27 23:00:00 | 8-K | | Stáhnout |
| 2024-03-27 00:00:00 | 8-K | | Stáhnout |
| 2024-03-26 23:00:00 | 8-K | | Stáhnout |
| 2024-03-05 00:00:00 | 8-K | | Stáhnout |
| 2024-03-04 23:00:00 | 8-K | | Stáhnout |
| 2024-03-04 00:00:00 | 8-K | | Stáhnout |
| 2024-03-03 23:00:00 | 8-K | | Stáhnout |
| 2024-02-28 00:00:00 | 8-K | | Stáhnout |
| 2024-02-27 23:00:00 | 8-K | | Stáhnout |
